Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Rachel L McDevitt"'
Autor:
Amy L. Pasternak, Robinson Seda, Joseph Lipa, Rachel L. McDevitt, Oxana V. Crysler, Paul L. Swiecicki, Bryan J. Schneider, Brett Vanderwerff, N. Lynn Henry, John C. Krauss, Vaibhav Sahai, Daniel L. Hertz
Publikováno v:
Clinical Pharmacology & Therapeutics.
Autor:
Valerie Gunchick, Rachel L McDevitt, Elizabeth Choi, Katherine Winslow, Mark M Zalupski, Vaibhav Sahai
Publikováno v:
The Oncologist.
Background Patients with advanced biliary tract cancers (BTCs) have poor prognoses and limited therapeutic options. Renin-angiotensin antagonists (ACE-I/ARBs), statins, and aspirin may have potential anti-tumorigenic effects and decrease mortality pe
Autor:
Angelina Y Jeong, Mary K. Oerline, Megan E.V. Caram, Rachel L McDevitt, Christine M. Veenstra, Andrea Roman, Eric B Schwartz, Elyssa Henry
Publikováno v:
JCO Oncol Pract
PURPOSE: Abiraterone and enzalutamide are commonly used oral cancer therapies for patients with prostate cancer, both with potentially high out-of-pocket costs for patients. We investigated the prevalence of financial assistance mechanisms used to al
Autor:
David Frame, Victoria R Nachar, Shawna Kraft, Jeffrey B. Smerage, Shannon Hough, Rachel L McDevitt, Catherine Christen, Anna Brown
Publikováno v:
JCO Oncology Practice. 17:e1303-e1310
PURPOSE: Chemotherapy-induced nausea and vomiting (CINV) is a common cause of unplanned healthcare utilization. The University of Michigan Rogel Cancer Center initiated the chemotherapy remote care monitoring program (CRCMP) to proactively identify p
Autor:
Catherine Christen, Morgan J Homan, Victoria R Nachar, Shawna Kraft, Justin H Reid, Lydia L. Benitez, Anna Brown, Shannon Hough, Rachel L McDevitt, David Frame
Publikováno v:
Supportive Care in Cancer. 29:6505-6510
Nausea, vomiting, constipation, and diarrhea are common cancer and cancer therapy adverse effects. Pharmacists are uniquely positioned to optimize patient symptom control and minimize excess use of hospital resources, such as emergency department vis
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:2014-2017
Introduction We report the case of a patient who experienced severe neurological symptoms collectively characterized as being “frozen” following a second oxaliplatin infusion. Case report A 52-year-old woman with metastatic colon cancer developed
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311652
Purpose The combination of paclitaxel, ifosfamide, and cisplatin (TIP) is frequently used for the treatment of metastatic germ cell tumors. Due to complex supportive care and infusion requirements, TIP is typically given in the inpatient setting. Thi
Publikováno v:
Journal of Onco-Nephrology. :239936932311606
Background: Bisphosphonates are the backbone of treatment for hypercalcemia of malignancy (HCM). However, concern regarding their safety in patients with renal dysfunction exists. The safety and effectiveness of bisphosphonates compared to other trea
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311587
Purpose Identify risk factors for biliary toxicity in patients with colorectal liver metastases who received floxuridine (FUDR) via a surgically implanted hepatic artery infusion pump (HAIP). Describe the incidence of biliary toxicity and evaluate re
Autor:
Ryan J. Beechinor, Rachel L. McDevitt
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5:1324-1324